Francisco, Lyka D.
HRN: 22-45-57 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/26/2023
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
05/26/2023
06/02/2023
IV DRIP
3grams
Q8
Sepsis
Waiting Final Action
Indication: Empiric Type of Infection: Unspecified Sepsis Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes